KORTUC Inc Overview

  • Founded
  • 2015
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 3

KORTUC Inc General Information


Developer of pharmaceuticals and medical devices intended to enhance cancer radiation therapy. The company develops an advanced radiation sensitizer injected into tumors prior to radiotherapy to increase the effectiveness of radiation treatment, thereby enabling medical professionals to control the radiated tumors and improve the efficacy of radiation therapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Primary Office
  • 1st Floor Otemachi Building, 1-6-1
  • Otemachi, Chiyoda-ku
  • Tokyo, 100-0004
  • Japan

KORTUC Inc Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KORTUC Inc Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 13-Dec-2019 00.000 Completed Startup
2. Early Stage VC 28-Dec-2017 00000 00.000 Completed Startup
1. Early Stage VC 28-Feb-2017 $885K $885K Completed Startup

KORTUC Inc Executive Team (2)

Name Title Board Seat Contact Info
Kazuyuki Matsuda Chief Executive Officer
Robert Kneller Chief Medical Officer

KORTUC Inc Investors (3)

To view KORTUC Inc‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sojitz Corporation Minority 000 0000 000000 0
Shikoku Bank Corporation Minority 000 0000 000000 0
Nissay Capital Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial